giving yourself a shot of semaglutide Week 1 on Semaglutide: Injection Experience Maximizing Your Semaglutide Injections |

Genetic variants in GLP1R, GIPR, FTO, and MC4R pathways correlate with differential treatment outcomes across injection, oral, and emerging transdermal formulations

You know, we're using GLP ones a lot in women with PCOS, even if they have lean PCOS

In the United States, Thymosin Alpha-1 is not FDA-approved for any therapeutic use and cannot be marketed as a treatment for infections, immune disorders, chronic illness, cancer support, or vaccine enhancement

FEHB Plan Coverage Weight-loss drugs are classified as GLP-1 (glucagon-like peptide-1) receptor agonists, and the ones approved by the FDA include Qsymia, Contrave, Saxenda, Wegovy, and Zepbound

Without ongoing lifestyle interventions, patients may regain 50-70% of lost weight within 12 months of stopping treatment

In January 2024, Geof published his first book, Now What